Drug:
Reaction: DYSPNOEA
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25126006 |
DE |
1 | |
Tremor, Dizziness, Peripheral vascular disorder, Weight increased, Gout, Dry mouth, Thirst, Fluid retention, Dyspnoea, Pruritus, Sleep disorder due to general medical condition, insomnia type, |
||||
IXEKIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ALLOPURINOL, |
||||
| 402 | 25126060 |
US |
2 | |
Dyspnoea, |
||||
RIVAROXABAN, AMLODIPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, PANTOPRAZOLE, TIOTROPIUM BROMIDE, CYCLOSPORINE, VALSARTAN, WARFARIN, VITAMIN C, ERGOCALCIFEROL, |
||||
| 403 | 25126113 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pyrexia, Rheumatoid arthritis, Sinusitis, Sleep disorder, Gastrointestinal disorder, Rash, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Wound, Weight increased, Hepatic enzyme increased, Insomnia, Fatigue, Arthralgia, Pruritus, Hypersensitivity, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, APREPITANT, LEFLUNOMIDE, CETRIMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, OXYCODONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, |
||||
| 404 | 25126139 |
US |
61 | 2 |
Sinus disorder, Pneumonia influenzal, Herpes zoster, Dyspnoea, Paraesthesia, Asthenia, |
||||
UPADACITINIB, |
||||
| 405 | 25126144 |
US |
31 | 1 |
Hyperhidrosis, Dyspnoea, Fatigue, Anger, |
||||
MACITENTAN, TREPROSTINIL, TREPROSTINIL, ERGOCALCIFEROL, SPIRONOLACTONE, MIRTAZAPINE, FAMOTIDINE, OXYGEN, 0XYGEN, OMEPRAZOLE MAGNESIUM, |
||||
| 406 | 25126202 |
CN |
69 | |
Cough, Breath holding, Dyspnoea, |
||||
BUDESONIDE, ACETYLCYSTEINE, |
||||
| 407 | 25115594 |
US |
60 | 1 |
Large intestinal haemorrhage, Crohn^s disease, Haematochezia, Gastrointestinal sounds abnormal, Dyspnoea, Musculoskeletal disorder, Haemoglobin decreased, Device issue, |
||||
RISANKIZUMAB-RZAA, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, AMLODIPINE, GLIMEPIRIDE, EMPAGLIFLOZIN, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RISANKIZUMAB-RZAA, |
||||
| 408 | 25115673 |
CA |
56 | 1 |
Idiopathic interstitial pneumonia, Abdominal distension, Adenoidectomy, Gastrooesophageal reflux disease, Headache, Hospitalisation, Increased appetite, Loss of personal independence in daily activities, Lung diffusion disorder, Mediastinal mass, Migraine, Mycobacterial infection, Nasal congestion, Nasal oedema, Nasal polyps, Obstructive airways disorder, Palpitations, Productive cough, Pulmonary eosinophilia, Pulmonary granuloma, Pulmonary mass, Respiratory disorder, Sleep disorder due to a general medical condition, Sputum discoloured, Therapeutic product effect incomplete, Tonsillectomy, Umbilical hernia, Vasculitis, Weight increased, Wheezing, Asthenia, Asthma, Atelectasis, Blood immunoglobulin E increased, Bronchial secretion retention, Bronchial wall thickening, Bronchiolitis, Chest discomfort, Chronic obstructive pulmonary disease, Diaphragmatic disorder, Dry mouth, Dyspnoea, Dyspnoea exertional, Emphysema, Eosinophil count increased, Full blood count abnormal, |
||||
IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, BUDESONIDE, PREDNISONE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 409 | 25115675 |
US |
||
Chronic obstructive pulmonary disease, Hypoaesthesia, Dyspnoea, Product dose omission issue, Incorrect dose administered, Device malfunction, Incorrect dose administered by device, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 410 | 25115693 |
GB |
76 | 1 |
Circulatory collapse, Hypokalaemia, Dyspnoea, Orthostatic hypotension, Loss of consciousness, |
||||
BISOPROLOL FUMARATE, BUMETANIDE, BUMETANIDE, BUMETANIDE, SPIRONOLACTONE, APIXABAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREGABALIN, DAPAGLIFLOZIN, LEVOTHYROXINE, RAMIPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 411 | 25115874 |
US |
2 | |
Dyspnoea, Oxygen saturation decreased, Anxiety, Weight increased, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 412 | 25115881 |
PL |
2 | |
Urticaria, Dyspnoea, Cough, Off label use, |
||||
URSODIOL, URSOSIOL, LEVOTHYROXINE, |
||||
| 413 | 25115894 |
US |
2 | |
Headache, Pain of skin, Neck pain, Musculoskeletal chest pain, Pleuritic pain, Dyspnoea, Abdominal pain upper, Dehydration, Influenza, Impaired work ability, Arthralgia, Back pain, Pain in extremity, |
||||
USTEKINUMAB, |
||||
| 414 | 25115965 |
US |
1 | |
Dyspnoea, Fatigue, |
||||
EVOLOCUMAB, |
||||
| 415 | 25115974 |
FR |
73 | 1 |
Tachypnoea, Dyspnoea, Asthenia, Dyspnoea, Hypertension, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 416 | 25116004 |
GB |
60 | 2 |
Malaise, Dyspnoea, |
||||
| 417 | 25116043 |
US |
45 | 2 |
Sleep apnoea syndrome, Pharyngeal disorder, Dysphonia, Dyspnoea, Oxygen saturation decreased, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 418 | 25116114 |
RU |
61 | 2 |
Face oedema, Oedema peripheral, Oxygen saturation decreased, Lung opacity, Skin maceration, Body temperature increased, Superficial vein thrombosis, Superficial vein thrombosis, Hyperaemia, Toxic skin eruption, Pneumonia, Rash, Serum ferritin increased, Fibrin D dimer increased, Blood urea increased, Blood creatinine increased, Synovial cyst, Erythema, Dyspnoea, Alanine aminotransferase increased, Aspartate aminotransferase increased, |
||||
BARICITINIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, RITONAVIR, RITONAVIR 100 MG, TOCILIZUMAB, HYDROXYCHLOROQUINE SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CEFTRIAXONE, CEFTRIAXONE SODIUM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, MEROPENEM, |
||||
| 419 | 25116182 |
US |
1 | |
Hospitalisation, Surgery, Cough, Malaise, Fatigue, Headache, Dyspnoea, Intentional dose omission, Product dose omission issue, Treatment noncompliance, Therapy interrupted, |
||||
AMIKACIN, |
||||
| 420 | 25116202 |
US |
2 | |
Dyspnoea, Disturbance in attention, Off label use, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, ALPRAZOLAM, |
||||
| 421 | 25116284 |
US |
66 | |
Device leakage, Product use issue, Inappropriate schedule of product administration, Feeling abnormal, Illness, Dyspnoea, |
||||
BENRALIZUMAB, |
||||
| 422 | 25116354 |
US |
||
Dizziness, Dyspnoea, Discomfort, |
||||
RELUGOLIX, ASCORBIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLONIDINE, COLCHICINE, EZETIMIBE, FERROUS SULFATE, GEMFIBROZIL, GLIPIZIDE, HYDROCHLOROTHIAZIDE, EPLERENONE, IRBESARTAN, LABETALOL HYDROCHLORIDE, LABETALOL, LANSOPRAZOLE, GEMFIBROZIL, MAGNESIUM OXIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MINOXIDIL, OIL, NIFEDIPINE, LANSOPRAZOLE, METOCLOPRAMIDE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 423 | 25116403 |
US |
56 | |
Dyspnoea, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 424 | 25116420 |
US |
||
Dyspnoea, Cough, Wheezing, Drug dose omission by device, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 425 | 25116425 |
NZ |
64 | 1 |
Crepitations, Wheezing, Dyspnoea, Hypertension, Upper respiratory tract infection, Chest discomfort, Speech latency, Chills, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, OXYCODONE, AMOXICILLIN AND CLAVULANATE POTASSIUM, GABAPENTIN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 426 | 25116520 |
US |
2 | |
Dyspnoea, Dyspnoea exertional, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 427 | 25116574 |
US |
28 | |
Dyspnoea, Insomnia, Dizziness, Adverse event, Drug dose omission by device, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, |
||||
| 428 | 25116688 |
US |
||
Dyspnoea, Pain in extremity, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 429 | 25116707 |
US |
||
Hypersensitivity, Condition aggravated, Dyspnoea, |
||||
| 430 | 25116745 |
US |
83 | 2 |
Dyspnoea, Dizziness, Fluid retention, Respiration abnormal, Exercise tolerance decreased, Gastrointestinal disorder, Drug ineffective, Therapy non-responder, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FAMOTIDINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, PRAVASTATIN SODIUM, SACUBITRIL AND VALSARTAN, ALBUTEROL SULFATE, ROSUVASTATIN CALCIUM, TADALAFIL, ALLOPURINOL, METHOTREXATE, METHOTREXATE SODIUM, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, IPRATROPIUM BROMIDE, FUROSEMIDE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, PREDNISONE, |
||||
| 431 | 25116783 |
US |
74 | 2 |
Dyspnoea, Illness, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
| 432 | 25116978 |
DK |
55 | 1 |
Dyspnoea, Fatigue, Vomiting, Dizziness, Ketoacidosis, Decreased appetite, Cough, Balance disorder, Type 1 diabetes mellitus, Hyperthyroidism, |
||||
ATEZOLIZUMAB, |
||||
| 433 | 25116983 |
US |
61 | 1 |
Cardiac disorder, Drug ineffective, Lung disorder, Drug ineffective, Fluid retention, Insomnia, Dyspnoea, Lethargy, Heart rate irregular, Arthritis, Asthenia, Osteoarthritis, Pneumonia, Pulmonary oedema, |
||||
ADALIMUMAB, ADALIMUMAB, GOLIMUMAB, GOLIMUMAB, ATENOLOL, PREDNISONE, APIXABAN, MELOXICAM, SECUKINUMAB, GABAPENTIN, NABUMETONE, ALLOPURINOL, |
||||
| 434 | 25117010 |
US |
||
Dyspnoea, Fatigue, Pruritus, Rhinorrhoea, |
||||
LENALIDOMIDE, |
||||
| 435 | 25117065 |
US |
74 | 2 |
Dyspnoea, Decreased appetite, Feeling abnormal, Vomiting, Diarrhoea, Nausea, |
||||
TIRZEPATIDE, |
||||
| 436 | 25117088 |
US |
2 | |
Throat tightness, Dyspnoea, Off label use, |
||||
TOCILIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 437 | 25117130 |
US |
63 | 2 |
Rheumatoid arthritis, Dyspnoea, Acne, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 438 | 25117135 |
JP |
||
Interstitial lung disease, Dyspnoea, Sputum retention, Therapeutic product effect incomplete, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 439 | 25117172 |
US |
1 | |
Choking sensation, Dyspnoea, Device malfunction, |
||||
TIOTROPIUM BROMIDE AND OLODATEROL, |
||||
| 440 | 25117240 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
| 441 | 25117367 |
US |
44 | 2 |
Vomiting, Diarrhoea, Nausea, Chest pain, Dyspnoea, Fatigue, Catheter site pain, Catheter site erythema, Catheter site discharge, Musculoskeletal chest pain, |
||||
TREPROSTINIL, TREPROSTINIL, PREDNISONE, RIVAROXABAN, SPIRONOLACTONE, DICLOFENAC SODIUM, MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, PANTOPRAZOLE SODIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FUROSEMIDE, POLYETHYLENE GLYCOL, STANDARDIZED SENNA CONCENTRATE, ESCITALOPRAM, IBUPROFEN, SILDENAFIL CITRATE, SILDENAFIL, AMBRISENTAN, |
||||
| 442 | 25117587 |
IR |
17 | 2 |
Respiratory failure, Disease progression, Leukopenia, Dyspnoea, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 443 | 25117852 |
US |
9 | 1 |
Dyspnoea, Chest discomfort, |
||||
GADOTERATE MEGLUMINE, |
||||
| 444 | 25117873 |
IN |
42 | |
Typhoid fever, Arthralgia, Back pain, Constipation, Abdominal distension, Mental disorder, Abdominal pain, Abdominal discomfort, Decreased appetite, Fatigue, Anxiety, Hepatic steatosis, Low density lipoprotein increased, Thyroid hormones increased, Dyspnoea, Pyrexia, Haemoglobin decreased, White blood cell count decreased, Weight decreased, |
||||
OLAPARIB, |
||||
| 445 | 25117878 |
US |
||
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 446 | 25117906 |
US |
1 | |
Cardiac arrest, Foaming at mouth, Madarosis, Pain, Dyspnoea, |
||||
FENTANYL, PROPOFOL, MELPHALAN, TOPOTECAN, ALBUTEROL SULFATE, ALBUTEROL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 447 | 25118046 |
KR |
44 | |
Pulmonary oedema, Stomatitis, Male reproductive tract disorder, Pruritus genital, Dyspnoea, Insomnia, Rhinorrhoea, Pericarditis, Diarrhoea, Dyschezia, |
||||
OSIMERTINIB, |
||||
| 448 | 25118059 |
CA |
60 | |
Pulmonary oedema, Lower respiratory tract congestion, Malaise, Body temperature increased, Cold sweat, Dyspnoea, Cough, Wheezing, Rhinorrhoea, Haemoptysis, Pyrexia, |
||||
BENRALIZUMAB, BENRALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 449 | 25118074 |
US |
||
Dyspnoea, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 450 | 25118090 |
US |
77 | 1 |
Dyspnoea, Chest discomfort, |
||||
| 451 | 25118095 |
US |
52 | 1 |
Throat tightness, Dyspnoea, |
||||
| 452 | 25118096 |
US |
57 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device malfunction, |
||||
ALBUTEROL SULFATE, |
||||
| 453 | 25118127 |
US |
||
Dyspnoea, Throat tightness, |
||||
| 454 | 25118192 |
US |
64 | |
Dyspnoea, Device delivery system issue, Drug dose omission by device, Device deposit issue, |
||||
ALBUTEROL SULFATE, |
||||
| 455 | 25118357 |
CN |
64 | 2 |
Infusion related reaction, Asphyxia, Dyspnoea, Cough, Abdominal pain upper, Chest discomfort, |
||||
DARATUMUMAB, |
||||
| 456 | 25118493 |
US |
70 | 2 |
Tonsillar hypertrophy, Sinusitis, Dyspnoea, |
||||
RIMEGEPANT SULFATE, |
||||
| 457 | 25118533 |
CA |
2 | |
Macular degeneration, Headache, Cough, Pain, Rectal tenesmus, Dyspnoea, Abdominal distension, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 458 | 25118549 |
US |
||
Positive airway pressure therapy, Dyspnoea, |
||||
BENRALIZUMAB, |
||||
| 459 | 25118576 |
US |
||
Bronchiectasis, Pulmonary haemorrhage, Bacterial infection, Chronic obstructive pulmonary disease, Wheezing, Therapy cessation, Dyspnoea, Breath odour, Epistaxis, Inflammation, Haemorrhage, Dysphonia, Speech disorder, Amnesia, Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 460 | 25118589 |
CA |
2 | |
Drug-induced liver injury, Fibromyalgia, Grip strength decreased, Dislocation of vertebra, Arthropathy, Gait inability, Fatigue, Delirium, Discomfort, Weight increased, Asthma, Systemic lupus erythematosus, Folliculitis, General physical health deterioration, Abdominal discomfort, Wound, Swollen joint count increased, Glossodynia, Bone erosion, Stomatitis, Autoimmune disorder, Bronchitis, Anti-cyclic citrullinated peptide antibody positive, Dizziness, Type 2 diabetes mellitus, Crohn^s disease, Depression, Ear infection, Foot deformity, Alopecia, Arthritis, Vomiting, Blood cholesterol increased, Swelling, Exostosis, Hand deformity, Headache, Anxiety, Dyspnoea, Anti-cyclic citrullinated peptide antibody, Wheezing, Synovitis, Decreased appetite, Tachycardia, Visual impairment, Duodenal ulcer perforation, Blister, Adjustment disorder with depressed mood, Deep vein thrombosis postoperative, Gait disturbance, Chest pain, C-reactive protein increased, Upper respiratory tract infection, Breast cancer stage III, Weight decreased, Urticaria, Condition aggravated, Arthralgia, Confusional state, Diarrhoea, Wound infection, Dyspepsia, Amnesia, Contusion, Disability, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Prescribed underdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Seronegative arthritis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Walking aid user, |
||||
CALCIUM CARBONATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, MESALAMINE, ERGOCALCIFEROL, ERGOCALCIFEROL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, PREGABALIN, USTEKINUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, AZATHIOPRINE, TOFACITINIB, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, CERTOLIZUMAB PEGOL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYCODONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, TRICLOSAN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRAMADOL HYDROCHLORIDE, VEDOLIZUMAB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CLONIDINE HYDROCHLORIDE, CLONIDINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ETANERCEPT, ETANERCEPT, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, GOLIMUMAB, |
||||
| 461 | 25118596 |
CA |
||
Blood glucose decreased, Blood magnesium decreased, Blood phosphorus decreased, Chest discomfort, Chest pain, Cough, Dyspnoea, Heart rate decreased, Hypotension, Malaise, |
||||
EVEROLIMUS, |
||||
| 462 | 25118626 |
CA |
64 | 1 |
Dyspnoea, Injection site pain, Fatigue, Hot flush, Dizziness, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 463 | 25118630 |
KR |
||
Pneumonia, Pneumothorax, Dyspnoea, Toxicity to various agents, |
||||
OSIMERTINIB, |
||||
| 464 | 25118657 |
CA |
53 | |
Asthma, Therapeutic product effect incomplete, Sleep disorder due to a general medical condition, Loss of personal independence in daily activities, Dyspnoea, Wheezing, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, ALBUTEROL SULFATE, |
||||
| 465 | 25118660 |
AU |
||
Neoplasm malignant, Lupus-like syndrome, Infection, Vasculitis, Drug specific antibody present, Infusion related reaction, Nausea, Abdominal pain, Fatigue, Arthralgia, Upper respiratory tract infection, Headache, Chest pain, Dyspnoea, Paraesthesia, Psoriasis, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 466 | 25118678 |
CN |
||
Death, Syncope, Dyspnoea, Central nervous system lesion, Bronchospasm, |
||||
DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 467 | 25118735 |
US |
||
Pneumonia, Bronchitis, Illness, Immunodeficiency, Dyspnoea, Respiratory muscle weakness, Device malfunction, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 468 | 25118786 |
DE |
14 | 1 |
Anaphylactic reaction, Flushing, Dyspnoea, Oxygen saturation decreased, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 469 | 25118797 |
US |
71 | 2 |
Arrhythmic storm, Cardiogenic shock, Cardiac arrest, Myocardial ischaemia, Cardiomyopathy, Septic shock, Cardiac valve disease, Lactic acidosis, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Dyspnoea, Orthopnoea, Toxicity to various agents, Accidental overdose, |
||||
FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, RIVAROXABAN, MOLNUPIRAVIR, |
||||
| 470 | 25118841 |
CA |
61 | |
Cough, Rash, Full blood count abnormal, Blood test abnormal, Bronchial secretion retention, Bronchial wall thickening, Bronchiectasis, Cyst, Dyspnoea, Hepatomegaly, Lung hyperinflation, Obstructive airways disorder, Skin lesion, Small airways disease, Spinal osteoarthritis, Sputum discoloured, Wheezing, Drug ineffective, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, MEPOLIZUMAB, MOMETASONE FUROATE, TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 471 | 25118925 |
US |
2 | |
Hepatic enzyme increased, Dyspnoea, Chest pain, Nasopharyngitis, |
||||
TIRZEPATIDE, |
||||
| 472 | 25118975 |
US |
31 | 1 |
Dyspnoea, |
||||
DUPILUMAB, ALBUTEROL SULFATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, PREDNISONE, |
||||
| 473 | 25119054 |
US |
57 | 2 |
Dyspnoea, Wheezing, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 474 | 25119136 |
US |
45 | 2 |
Nasal congestion, Dyspnoea, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 475 | 25119193 |
US |
56 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
| 476 | 25119287 |
US |
||
Abdominal discomfort, Flatulence, Dyspnoea, Headache, Extra dose administered, Product taste abnormal, |
||||
AMPHETAMINE, |
||||
| 477 | 25119298 |
CA |
56 | 2 |
Dyspnoea, Heart rate increased, Neuropathy peripheral, COVID-19, Chest discomfort, Cough, Localised infection, Neutrophil count decreased, Peripheral swelling, Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 478 | 25119391 |
US |
91 | 1 |
Neuropathy peripheral, Restless legs syndrome, Condition aggravated, Weight decreased, Middle insomnia, Decreased appetite, Nausea, Salivary hypersecretion, Vomiting, Asthenia, Malaise, Anaemia, Dyspnoea, Abdominal pain upper, Hot flush, |
||||
ENZALUTAMIDE, ENZALUTAMIDE, ENZALUTAMIDE, ALPRAZOLAM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DENOSUMAB, LEUPROLIDE ACETATE, |
||||
| 479 | 25119417 |
US |
76 | 1 |
Avian influenza, Dyspnoea, Dysphonia, Pharyngeal swelling, Limb discomfort, Amnesia, Peripheral swelling, Condition aggravated, Loss of personal independence in daily activities, Asthenia, |
||||
DUPILUMAB, |
||||
| 480 | 25119437 |
DZ |
2 | |
Cardiac arrest, Tachycardia, Dyspnoea, |
||||
NATALIZUMAB, |
||||
| 481 | 25119515 |
FR |
||
Gait disturbance, Musculoskeletal pain, Dyspnoea, Rash macular, Weight increased, |
||||
DEGARELIX, DEGARELIX, |
||||
| 482 | 25119579 |
US |
2 | |
Blood pressure fluctuation, Chest discomfort, Dyspnoea, Hypoaesthesia, Pyrexia, |
||||
GUSELKUMAB, |
||||
| 483 | 25119768 |
CA |
65 | 1 |
Antineutrophil cytoplasmic antibody positive, Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma, Capillaritis, Condition aggravated, Conjunctivitis allergic, Death, Dust allergy, Dyspnoea, Eosinophilic granulomatosis with polyangiitis, Forced expiratory volume decreased, Full blood count abnormal, Haemoptysis, Hypothyroidism, Hypoxia, Lung disorder, Loss of personal independence in daily activities, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Productive cough, Pulmonary alveolar haemorrhage, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Sleep disorder due to a general medical condition, Spirometry abnormal, Therapeutic product effect incomplete, Thrombosis, Total lung capacity abnormal, Wheezing, Vasculitis, |
||||
CEPHALEXIN, CEPHALEXIN, CEPHALEXIN, CEPHALEXIN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BUDESONIDE, BUDESONIDE, CALCIUM SENNOSIDES, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CICLESONIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, APIXABAN, ERGOCALCIFEROL, ESCITALOPRAM OXALATE, ESCITALOPRAM, FINASTERIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, GLUCAGON, GLUCAGON, GLUCAGON, GLUCAGON, GLUCAGON, GLUCAGON, GLUCAGON, GLUCAGON, GLUCAGON, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOTHYROXINE, LIRAGLUTIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MEPOLIZUMAB, CICLESONIDE, PENICILLIN G, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SENNOSIDES, SENNOSIDES, SENNOSIDES, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, TIOTROPIUM BROMIDE, SULFADIAZINE, DILTIAZEM HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, UMECLIDINIUM, ROSUVASTATIN CALCIUM, |
||||
| 484 | 25119778 |
US |
85 | 1 |
Dyspnoea, Treatment noncompliance, Drug ineffective, |
||||
ALBUTEROL SULFATE, |
||||
| 485 | 25119785 |
CN |
59 | 1 |
Oxygen saturation decreased, Chest discomfort, Dyspnoea, |
||||
CETUXIMAB, |
||||
| 486 | 25119845 |
CA |
80 | 2 |
Head injury, Cardiac failure, Asthenia, Atrial fibrillation, Dizziness postural, Dyspnoea, Fatigue, Heart rate increased, Hypotension, Syncope, Intentional dose omission, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, CITALOPRAM, CITALOPRAM, CITALOPRAM, CITALOPRAM, APIXABAN, APIXABAN, APIXABAN, APIXABAN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, VALSARTAN, VALSARTAN, VALSARTAN, VALSARTAN, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 487 | 25119918 |
CA |
2 | |
Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CLONIDINE HYDROCHLORIDE, CLONIDINE, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SULFASALAZINE, SULFASALAZINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 488 | 25119923 |
AE |
61 | 1 |
Pyrexia, Dyspnoea, |
||||
TRIFLURIDINE AND TIPIRACIL, |
||||
| 489 | 25119959 |
NL |
82 | 2 |
Dry mouth, Cough, Dyspnoea, Diarrhoea, Anxiety, Nervousness, Oropharyngeal discomfort, Decreased appetite, Salivary hyposecretion, Confusional state, Nausea, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 490 | 25120014 |
CA |
1 | |
Oxygen saturation decreased, Discomfort, Dyspnoea, Heart rate irregular, Blood pressure fluctuation, Heart rate increased, Blood pressure decreased, Extra dose administered, Blood pressure systolic decreased, Blood pressure diastolic increased, |
||||
IPRATROPIUM BROMIDE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ERGOCALCIFEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 491 | 25120057 |
US |
||
Neuropathy peripheral, Autoimmune disorder, Somnolence, Dyspnoea, Wheezing, Fall, Foot fracture, Ankle fracture, Muscle fatigue, Fatigue, Asthenia, |
||||
RAVULIZUMAB, GABAPENTIN, |
||||
| 492 | 25120144 |
US |
2 | |
Dyspnoea, Pain, Feeling abnormal, Fatigue, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, |
||||
| 493 | 25120180 |
CA |
2 | |
Asthma, Dyspnoea, Eosinophil count abnormal, Loss of personal independence in daily activities, Obstructive airways disorder, Osteopenia, Sinus disorder, Sleep disorder due to a general medical condition, Wheezing, Therapeutic product effect incomplete, |
||||
ALBUTEROL SULFATE, ALBUTEROL, MEPOLIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 494 | 25120248 |
79 | 1 | |
Anaemia, Leukopenia, Acute kidney injury, Urinary tract infection, Haematuria, Thrombosis, Unresponsive to stimuli, Pulseless electrical activity, Nausea, Dizziness, Tryptase increased, Abdominal pain, Hypotension, Dyspnoea, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, APIXABAN, |
||||
| 495 | 25120259 |
NL |
46 | 1 |
Dyspnoea, Chest pain, |
||||
INSULIN GLULISINE, IRBESARTAN, METOPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, ORAL SEMAGLUTIDE, |
||||
| 496 | 25120343 |
US |
||
Asthma, Malaise, Sleep apnoea syndrome, Headache, Dyspnoea, Chronic obstructive pulmonary disease, Fatigue, Asthenia, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 497 | 25120382 |
50 | 2 | |
Chest pain, Dyspnoea, Nausea, Vomiting, |
||||
ADALIMUMAB, |
||||
| 498 | 25120528 |
AU |
66 | 1 |
Hypoaesthesia oral, Dyspnoea, Sneezing, Rash macular, |
||||
GADOTERATE MEGLUMINE, |
||||
| 499 | 25120571 |
US |
55 | 2 |
Gait inability, Metastases to lung, Speech disorder, Viral infection, Drug intolerance, Illness, Dyspnoea, Dyspnoea, |
||||
REGORAFENIB, REGORAFENIB, CAPECITABINE, |
||||
| 500 | 25120688 |
US |
||
Dyspnoea, |
||||
BENRALIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28